Effects of atorvastatin and l-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 5, 2010, Pages 498-505

  Ozturk, Elif Inci ^a   Uma, Serdar ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

EFS; L arginine; MCT; pulmonary artery; statin

Indexed keywords

ACETYLCHOLINE; ARGININE; ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MONOCROTALINE; NITROPRUSSIDE SODIUM; PAPAVERINE; PHENYLEPHRINE; PINACIDIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT;

ANIMALS; ARGININE; ELECTRIC STIMULATION; ENDOTHELIUM, VASCULAR; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PULMONARY ARTERY; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 78650178983     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181f4838b     Document Type: Article

References (39)

1. Nakazawa H, Hori M, Ozaki H, et al. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats. Br J Pharmacol. 1999;128:1098-1104.
2. Mathew R, Yuan N, Rosenfeld L, et al. Effects of monocrotaline on endothelial nitric oxide synthase expression and sulfhydryl levels in rat lungs. Heart Dis. 2002;4:152-158.
3. Leeman M, Naeije R. Nitric oxide and hypoxic pulmonary hypertension. Eur Respir J. 1995;8:513-514.
4. Ito KM, Sato M, Ushijima K, et al. Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries. Am J Physiol Heart Circ Physiol. 2000;279:H1786-H1795.
5. Mehta S, Stewart DJ, Langleben D, et al. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation. 1995;92:1539-1545.
6. Sumou IK, Du JB, Wei B, et al. Effect of L-arginine on pulmonary artery smooth muscle cell apoptosis in rats with hypoxic pulmonary vascular structural remodeling. Acta Biochim Biophys Sin (Shanghai). 2006;38: 15-21.
7. Eddahibi S, Adnot S, Carville C, et al. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol. 1992;263:L194-L200.
8. Nagaya N, Uematsu M, Oya H, et al. Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med. 2001; 163:887-891.
9. Goret L, Reboul C, Tanguy S, et al. Training does not affect the alteration in pulmonary artery vasoreactivity in pulmonary hypertensive rats. Eur J Pharmacol. 2005;527:121-128.
10. Mitani Y, Maruyama K, Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation. 1997;96:689-697.
11. Goret L, Tanguy S, Guiraud I, et al. Acute administration of l-arginine restores nitric oxide-mediated relaxation in isolated pulmonary arteries from pulmonary hypertensive exercise trained rats. Eur J Pharmacol. 2008;581:148-156.
12. Cheng W, Oike M, Hirakawa M, et al. Excess l-arginine restores endothelium-dependent relaxation impaired by monocrotaline pyrrole. Toxicol Appl Pharmacol. 2005;207:187-194.
13. Rakotoniaina Z, Guerard P, Lirussi F, et al. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin. Naunyn Schmiedebergs Arch Pharmacol. 2006;374:195-206.
14. Nishimura T, Vaszar LT, Faul JL, et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation. 2003;108:1640-1645.
15. Laufs U, Liao JK. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med. 2000;10:143-148.
16. Guerard P, Rakotoniaina Z, Goirand F, et al. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS. Naunyn Schmiedebergs Arch Pharmacol. 2006;373:401-414.
17. Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97: 1129-1135.
18. Nishimura T, Faul JL, Berry GJ, et al. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med. 2002;166:1403-1408.
19. Gumusel B, Orhan D, Tolunay O, et al. The role of nitric oxide in mediating nonadrenergic, noncholinergic relaxation in rat pulmonary artery. Nitric Oxide. 2001;5:296-301.
20. Altiere RJ, Olson JW, Gillespie MN. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension. J Pharmacol Exp Ther. 1986;236:390-395.
21. McCaig CD, Rajnicek AM, Song B, et al. Has electrical growth cone guidance found its potential? Trends Neurosci. 2002;25:354-359.
22. Zhao M, Bai H, Wang E, et al. Electrical stimulation directly induces pre-angiogenic responses in vascular endothelial cells by signaling through VEGF receptors. J Cell Sci. 2004;117:397-405.
23. Bakhle YS, Reynard AM, Vane JR. Metabolism of the angiotensins in isolated perfused tissues. Nature. 1969;222:956-959.
24. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun. 1989;164:714-721.
25. Gold ME, Wood KS, Buga GM, et al. L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. Biochem Biophys Res Commun. 1989;161:536-543.
26. Dhein S, Giessler C, Heinroth-Hoffmann I, et al. Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:87-95.
27. Oriowo MA. Chloride channels and alpha1-adrenoceptor-mediated pulmonary artery smooth muscle contraction: effect of pulmonary hypertension. Eur J Pharmacol. 2004;506:157-163.
28. Fox AP, Nowycky MC, Tsien RW. Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones. J Physiol. 1987;394:149-172.
29. Li L, van Breemen C. Agonist-and CPA-induced elevation of cytoplasmic free Ca2+ in intact valvular endothelium from rabbits. Am J Physiol. 1996;270:H837-H848.
30. Tomioka H, Hattori Y, Fukao M, et al. Role of endothelial Ni(2+)-sensitive Ca(2+) entry pathway in regulation of EDHF in porcine coronary artery. Am J Physiol Heart Circ Physiol. 2001;280:H730-H737.
31. Fadel AA, Barbee KA, Jaron D. A computational model of nitric oxide production and transport in a parallel plate flow chamber. Ann Biomed Eng. 2009;37:943-954.
32. Wang DI, Gotlieb AI. Fibroblast growth factor 2 enhances early stages of in vitro endothelial repair by microfilament bundle reorganization and cell elongation. Exp Mol Pathol. 1999;66:179-190.
33. Tzima E, del Pozo MA, Shattil SJ, et al. Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskel-etal alignment. EMBO J. 2001;20:4639-4647.
34. Korenaga R, Ando J, Tsuboi H, et al. Laminar-flow stimulates Atp-and shear stress-dependent nitric-oxide production in cultured bovine endothelial-cells. Biochem Biophys Res Commun. 1994;198:213-219.
35. Kuchan MJ, Frangos JA. Role of calcium and calmodulin in flow-induced nitric-oxide production in endothelial-cells. Am J Physiol. 1994;266: C628-C636.
36. Nishida K, Harrison DG, Navas JP, et al. Molecular-cloning and characterization of the constitutive bovine aortic endothelial-cell nitric-oxide synthase. J Clin Invest. 1992;90:2092-2096.
37. Noris M, Morigi M, Donadelli R, et al. Nitric-oxide synthesis by cultured endothelial-cells is modulated by flow conditions. Circ Res. 1995;76: 536-543.
38. Ozkan MH, Uma S. Does Endothelium-derived hyperpolarizing factor play a role in endothelium-dependent component of electrical field stimulation-induced vasorelaxation of rat mesenteric arterial rings? J Cardiovasc Pharmacol. 2009;53:30-37.
39. Matlung HL, Bakker EN, Vanbavel E.Shear stress, reactive oxygen species and arterial structure and function. Antioxid Redox Signal. 2009;11:1699-1709.